As part of the name change, the company will roll out a new corporate brand identity in July 2018, which will include new imagery and web site, and will trade under a new symbol, BHC.
Roughly 15% of the sildenafil market now belongs the brand-name erectile dysfunction drug, with the generic cornering the market, drug pricing site GoodRx recently highlighted on its blog.
With its newly minted pharmacy benefit management segment up and running and its CEO search nearing an end, Diplomat hit record revenues in Q1, but still swung to a $500,000 loss.
Fred’s will be selling its EntrustRx specialty pharmacy to a CVS Health subsidiary for $40 million, plus the value of the specialty pharmacy’s inventory.
The deal adds to Lannett’s portfolio various oral solutions and semi-solid products that had more than $175 million in sales for the 12 months ended in March, according to IQVIA data.
The Bentonville, Ark.-based company’s main effort will be limiting initial opioid prescriptions for acute conditions to no more than a seven-day supply, with a daily 50-morphine-mg-equivalent maximum.
